Showing results (291-300 of 1,289) with videos related to
Sort By:
Pageof 129
Journal of Comparative Effectiveness Research|June 20, 2023
Cost-utility analysis of mogamulizumab in advanced mycosis fungoides and Sézary syndrome cutaneous T-cell lymphomaNoemi Muszbek, Edit Remak, Qian Xin, et al.Journal of Comparative Effectiveness Research|August 3, 2026
Treatment gaps in osteoporosis care following recurrent fractures: a nationwide cohort studyHyun Jin Han, Miryoung Kim, Eyoung Wang, et al.Journal of Comparative Effectiveness Research|July 15, 2026
A disease progression model comparing the long-term mobility and respiratory outcomes of adults with late-onset Pompe disease receiving cipaglucosidase alfa plus miglustat versus alglucosidase alfaAmy Dymond, Will Green, Matthew Crabtree, et al.Journal of Comparative Effectiveness Research|June 26, 2026
Covariate selection and adjustment for efficacy and safety endpoints in indirect comparative effectiveness analyses of CAR-T-cell therapies for large B-cell lymphoma: a systematic reviewMarie A-C Neumann, Jonas Jost, Sybille Riou, et al.Journal of Comparative Effectiveness Research|May 23, 2019
An evidence-based model to consolidate medication adherence cost estimation: the medication adherence cost estimation frameworkRachelle L Cutler, Naomi Van der Linden, Shalom I Charlie Benrimoj, et al.Journal of Comparative Effectiveness Research|February 12, 2021
Cost-effectiveness analysis of empagliflozin compared with glimepiride in patients with Type 2 diabetes in ChinaAhmed Salem, Peng Men, Mafalda Ramos, et al.Journal of Comparative Effectiveness Research|February 10, 2021
Cost-per-remitter with esketamine nasal spray versus standard of care for treatment-resistant depressionUrvi Desai, Noam Y Kirson, Andrea Guglielmo, et al.Journal of Comparative Effectiveness Research|September 28, 2022
Developing a cross-validation tool for evaluating economic evidence in rapid literature reviewsXuanqian Xie, Chunmei Li, Sean Tiggelaar, et al.Journal of Comparative Effectiveness Research|November 4, 2022
Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam in the long-term care setting in the USADarshan Mehta, Inyoung Lee, Hangcheng Liu, et al.Journal of Comparative Effectiveness Research|November 19, 2013
Use of relative effectiveness information in reimbursement and pricing decisions in EuropeFloortje van Nooten, J Jaime CaroPageof 129